Why the study?
Does a 21-day Himalayan trek to 5490 m alter cardiopulmonary function in normal subjects?
Does a 21-day Himalayan trek to 5490 m alter cardiopulmonary function in normal subjects?
A 21-day high-altitude trek improves cardiovascular fitness in normal subjects but decreases pulmonary function, particularly in those who develop acute mountain sickness.
High-altitude trekking may enhance fitness while reducing pulmonary function; hypothesis-generating and should not change practice.
The heart rate response to exercise was studied in 17 normal subjects before, during and after a 21-day Himalayan trek to 5490 m. The group were fitter before the trek when compared to normal subjects of a similar age (P less than 0.001) having a lower heart rate response to exercise for their lean body mass. The trek significantly increased the 'fitness' of the group as a whole (P less than 0.025) but this was not seen in the 5 members of the group who had severe acute mountain sickness. Similar changes were noted within the first 8 days of the trek before symptoms of mountain sickness occurred. The group had normal pulmonary function before the trek but peak expiratory flow rate and vital capacity decreased with altitude. The effect was more marked in the subjects with acute mountain sickness.
No takes yet. Share an insight, caveat, or question.
Stockley et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: